Menu
Joel Lexchin
-
Prescription drug prices are very likely to increase in Canada
Canada has a drug price problem, and it risks getting a lot worse in the near future. Canadian prices for patented drugs are already the…
-
Busting neoliberal myths about pharmacare in Canada
Pharmacare is in the news again. The CD Howe Institute—an important neoliberal think tank—has just released a report based on a conference it hosted on…
-
Money makes drug regulation go round at Health Canada
In one of the songs in the musical Cabaret, there’s a refrain that goes “Money makes the world go round”. That’s true in most areas,…
-
How Health Canada can improve transparency in drug inspections
We all want to be sure that when we take medications, they have been manufactured under what are commonly known as Good Manufacturing Practices (GMP).…
-
Leave the patchwork for the quilts: The case for national pharmacare
FEBRUARY 2, 2015 The Canadian Health Coalition (CHC) was founded in 1979 as a public advocacy organization dedicated to the preservation and improvement of medicare.…
-
Canada’s cosy relationship with the pharmaceutical industry has a long history
News of government cooperation with the industry isn’t a surprise; it’s been going on for decades.
-
Want to see if your drug is safe? Health Canada has made it harder
Being able to access older information is vital to understanding how well Health Canada’s drug safety system is working
-
Would pharmacare spell trouble for drug companies?
The ongoing COVID-19 pandemic has brought the issue of prescription drug access back to the fore as questions of affordable access became international news in…
-
How pharmacare can offset higher drug prices post-CETA
Canada recently dodged a bullet when the House Democrats negotiated the removal of extended periods of monopoly protection for biologic drugs, such as treatments for…
-
Why high U.S. drug prices matter to Canada
Photo by ccPixs.com, Flickr Creative Commons. In the mid-1970s the average monthly cost of a cancer drug in the United States was about $100. By 1995 that…
-
The Ford government’s superficial arguments against pharmacare
Ontario’s new Progressive Conservative government is rejigging OHIP+, a modest but promising pharmacare policy introduced by the previous Liberal government, allegedly to make more efficient…
Updates from the CCPA
Read the latest research, analysis and commentary on issues that matter to you.
CCPA Updates